Literature DB >> 4830499

Effects of patient selection on results of phase II chemotherapy trials in gastrointestinal cancer.

C G Moertel, A J Schutt, R G Hahn, R J Reitemeier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4830499

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  3 in total

1.  Epirubicin in colorectal cancer. A phase II study of the early clinical trials group (EORTC).

Authors:  E E Holdener; H H Hansen; H Høst; U Bruntsch; F Cavalli; J Renard; H M Pinedo; M Rozencweig
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

2.  Blood transfusion: an overused resource in colorectal cancer surgery.

Authors:  M T Hallissey; M C Crowson; R S Kiff; R D Kingston; J W Fielding
Journal:  Ann R Coll Surg Engl       Date:  1992-01       Impact factor: 1.891

3.  Management of trials in the development of cancer chemotherapy.

Authors:  C J Williams; S K Carter
Journal:  Br J Cancer       Date:  1978-03       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.